BROADWOOD CAPITAL INC Long-Term Concentrated

Location: New York, NY

CIK: 0001278387 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 14, 2022

Total Value: $1.629B (100.0% shares, 0.0% debt)

Holdings (7)

STAA STAAR SURGICAL CO 48.2%

Value $784M Shares 8,592,007 Est. Cost $8.21 Unrealized +1206.7%

MNST MONSTER BEVERAGE CORP NEW 27.5%

Value $447M Shares 4,656,488 Est. Cost $22.71 Unrealized +95.8%

IWM ISHARES TR 9.4%

Value $153M Shares 690,000 Est. Cost $112.69 Unrealized —

AXON AXON ENTERPRISE INC 7.3%

Value $119M Shares 760,062 Est. Cost $27.50 Unrealized +510.6%

LCTX LINEAGE CELL THERAPEUTICS IN 5.1%

Value $83.31M Shares 34,005,379 Est. Cost $1.03 Unrealized +127.1%

— ONCOCYTE CORP 2.3%

Value $37.65M Shares 17,349,945 Est. Cost $3.38 Unrealized —

— AGEX THERAPEUTICS INC 0.2%

Value $3.267M Shares 2,997,156 Est. Cost $2.99 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
STAA	STAAR SURGICAL CO	8,592,007	$784M	48.2%	$8.21	+1206.7%	COM PAR $0.01	852312305
MNST	MONSTER BEVERAGE CORP NEW	4,656,488	$447M	27.5%	$22.71	+95.8%	COM	61174X109
IWM	ISHARES TR	690,000	$153M	9.4%	$112.69	—	RUSSELL 2000 ETF	464287655
AXON	AXON ENTERPRISE INC	760,062	$119M	7.3%	$27.50	+510.6%	COM	05464C101
LCTX	LINEAGE CELL THERAPEUTICS IN	34,005,379	$83.31M	5.1%	$1.03	+127.1%	COM	53566P109
—	ONCOCYTE CORP	17,349,945	$37.65M	2.3%	$3.38	—	COM	68235C107
—	AGEX THERAPEUTICS INC	2,997,156	$3.267M	0.2%	$2.99	—	COM	00848H108